Objective: To increase identification and genetic referral rates for women at risk of Hereditary Breast and Ovarian Cancer (HBOC). Design: Evidence-based practice improvement initiative Setting/Local Problem: Private suburban OB/GYN practice in Tennessee with no standardized process for HBOC risk assessment or genetic referral. Participants: Women age 18 or older, presenting for routine well-woman visits. Intervention/Measurements: Using PDSA (plan-do-study-act) cycles, a familial risk assessment tool was selected, and a clinical decision-making algorithm for risk assessment and genetic referral was designed and implemented for use in well-woman encounters. Pre-implementation and post-implementation risk identification and referral rate...
PURPOSE: To examine referral source to cancer genetic services; communication of results of genetic ...
BackgroundIn 2005, the United States Preventive Services Task Force (USPSTF) released guidelines whi...
OBJECTIVES: Hereditary Breast and Ovarian Cancer (HBOC) is an autosomal dominant cancer predispositi...
Approved May 2017 by the faculty of UMKC in partial fulfillment of the requirements for the degree ...
Breast cancer is the second leading cause of cancer death and the leading cause of premature death o...
The Michigan Department of Health and Human Services implemented and evaluated two initiatives desig...
BackgroundGuidelines recommend genetic counseling and testing for women with a pedigree suggestive o...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
Background/Aims: Systematically identifying and referring women at high risk of hereditary breast an...
Background: Approximately 1/300 individuals in the general population are at risk for hereditary bre...
Identification of risk for the hereditary breast and ovarian cancer syndrome (HBOC) is important, as...
BackgroundEvidence shows underutilization of cancer genetics services. To explore the reasons behind...
Gynaecological malignancy may be the sentinel cancer in women with Hereditary Breast-Ovarian Cancer ...
Genetics and genomics has changed the landscape of healthcare. It is now recommended that all obstet...
Genetic counseling and testing is important for families with a strong history of breast and ovarian...
PURPOSE: To examine referral source to cancer genetic services; communication of results of genetic ...
BackgroundIn 2005, the United States Preventive Services Task Force (USPSTF) released guidelines whi...
OBJECTIVES: Hereditary Breast and Ovarian Cancer (HBOC) is an autosomal dominant cancer predispositi...
Approved May 2017 by the faculty of UMKC in partial fulfillment of the requirements for the degree ...
Breast cancer is the second leading cause of cancer death and the leading cause of premature death o...
The Michigan Department of Health and Human Services implemented and evaluated two initiatives desig...
BackgroundGuidelines recommend genetic counseling and testing for women with a pedigree suggestive o...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
Background/Aims: Systematically identifying and referring women at high risk of hereditary breast an...
Background: Approximately 1/300 individuals in the general population are at risk for hereditary bre...
Identification of risk for the hereditary breast and ovarian cancer syndrome (HBOC) is important, as...
BackgroundEvidence shows underutilization of cancer genetics services. To explore the reasons behind...
Gynaecological malignancy may be the sentinel cancer in women with Hereditary Breast-Ovarian Cancer ...
Genetics and genomics has changed the landscape of healthcare. It is now recommended that all obstet...
Genetic counseling and testing is important for families with a strong history of breast and ovarian...
PURPOSE: To examine referral source to cancer genetic services; communication of results of genetic ...
BackgroundIn 2005, the United States Preventive Services Task Force (USPSTF) released guidelines whi...
OBJECTIVES: Hereditary Breast and Ovarian Cancer (HBOC) is an autosomal dominant cancer predispositi...